OM:ENZYPharmaceuticals
Enzymatica Second Quarter 2025 Earnings: kr0.06 loss per share (vs kr0.08 loss in 2Q 2024)
Enzymatica ( STO:ENZY ) Second Quarter 2025 Results Key Financial Results Revenue: kr8.28m (up 29% from 2Q 2024). Net...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.